|Articles|April 1, 1998

Clinical and Economic Considerations of Helicobacter pylori Eradication and Screening
Volume 4
Issue 5 Suppl

CPE Quiz

Articles in this issue

over 28 years ago

Article

Participating Faculty

over 28 years ago

Article

The Impact of H Pylori Eradication on Your Pharmacy Budget

over 28 years ago

Article

Overview of H pylori in Peptic Ulcer Disease

over 28 years ago

Article

Clinical Issues and Cost Effectiveness of Treating H pylori

over 28 years ago

Article

Current Issues in H pylori Eradication

over 28 years ago

Article

Evaluation of Outcomes Achieved Through Peptic Ulcer Disease State Management

over 28 years ago

Article

Is Curing Peptic Ulcer Disease an Oxymoron? A Focus on Helicobacter pylori

over 28 years ago

Article

Selected Abstracts

over 28 years ago

Article

Bibliography

over 28 years ago

Article

Efficacy and Economic Concerns Regarding H pylori Treatment in the Managed Care Setting

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

CPE Quiz

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Trump Childhood Vaccine Order: What It Means for Parents and Payers

FDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition

Orelabrutinib Cuts Progression Risk 68% in Frontline CLL/SLL

Extreme Heat May Increase Microplastic Exposure, Related Health Concerns: Eva R. Parker, MD

Obesity Alters Psoriasis Severity and Biologic Response, Review Finds